Common mineral could boost cancer treatment
NCT ID NCT07149649
Summary
This study is testing whether adding magnesium supplements to standard chemo-immunotherapy helps people with advanced non-small cell lung cancer. Magnesium is important for immune function, and chemotherapy often lowers magnesium levels. Researchers will randomly give 230 participants either magnesium or a placebo along with their standard treatment to see if magnesium improves outcomes and is well-tolerated.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kantonsspital - St. Gallen
Sankt Gallen, CH-9007, Switzerland
-
Kantonsspital Aarau
Aarau, CH-5001, Switzerland
-
Kantonsspital Baden
Baden, 5404, Switzerland
-
Kantonsspital Graubuenden
Chur, CH-7000, Switzerland
-
Kantonsspital Olten
Olten, 4600, Switzerland
-
Kantonsspital Winterthur
Winterthur, 8401, Switzerland
-
Luzerner Kantonsspital
Lucerne, 6000, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Spital STS AG
Thun, 3600, Switzerland
-
St. Claraspital
Basel, 4058, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Tumorzentrum Aarau - Hirslanden TZA
Aarau, 5001, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Universitätsspital Basel
Basel, 4058, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.